125 related articles for article (PubMed ID: 38661146)
21. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
[TBL] [Abstract][Full Text] [Related]
22. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
23. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
24. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
[TBL] [Abstract][Full Text] [Related]
25. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
[TBL] [Abstract][Full Text] [Related]
26. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
27. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
[TBL] [Abstract][Full Text] [Related]
28. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
[TBL] [Abstract][Full Text] [Related]
29. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
30. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
[TBL] [Abstract][Full Text] [Related]
31. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
[TBL] [Abstract][Full Text] [Related]
32. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y;
Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of endotoxin activity and Polymyxin-B hemoperfusion in critically ill patients with septic cardiomyopathy: A single-center, retrospective, observational study.
Cutuli SL; Carelli S; Cascarano L; Cicconi S; Silvestri D; Cicetti M; Vallecoccia MS; Pintaudi G; Tanzarella ES; Grieco DL; Antonelli M; De Pascale G
Artif Organs; 2023 Dec; 47(12):1865-1873. PubMed ID: 37737449
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
[TBL] [Abstract][Full Text] [Related]
36. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
Uriu K; Osajima A; Kamochi M; Watanabe H; Aibara K; Kaizu K
Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
[TBL] [Abstract][Full Text] [Related]
37. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
Ishizuka M; Tago K; Kubota K
Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
[TBL] [Abstract][Full Text] [Related]
38. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
[TBL] [Abstract][Full Text] [Related]
39. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
Maekawa H; Negishi K
Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
[TBL] [Abstract][Full Text] [Related]
40. Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion.
Sekino M; Murakami Y; Sato S; Shintani R; Kaneko S; Iwasaki N; Araki H; Ichinomiya T; Higashijima U; Hara T
Sci Rep; 2023 May; 13(1):7295. PubMed ID: 37147345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
